Dental News - Novalar enters licence agreement for launching OraVerse in Germany

Daniel Zimmermann, DTI

Fri. 5 March 2010

save

NEW YORK, USA/LEIPZIG, Germany: Novalar Pharmaceuticals has announced to have chosen Sanofi-Aventis Deutschland as exclusive distributor of their OraVerse anestethia reversal technology in Germany. Sanofi-Aventis, one of the leading German pharmaceutical companies, will also have the option to extend the license to other countries in Europe, both companies said. They intend to launch the product in early 2011.

OraVerse is a local anesthesia reversal agent that is said to accelerate the return of normal sensation and function following routine dental procedures. It is indicated for the reversal of soft tissue anesthesia, i.e., anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor. OraVerse is indicated for use only in adults and children 6 years of age or older and weighing at least 15 kg.

“As the largest dental market for local anesthetics in Europe, Germany represents a significant opportunity for the introduction of OraVerse,” said Donna Janson, President and Chief Executive Officer at Novalar. “Sanofi-Aventis do not only bring strong brand recognition and expertise in the European regulatory process but also demonstrated success in the dental industry. Their commercial network of will enable rapid penetration and reach into the target market.”

She added that applications for Marketing Authorization in several European countries will be submitted shortly.

To post a reply please login or register

LED Medical Diagnostics enters into agreement with OrthoSynetics

NEW YORK, N.Y., USA: LED Medical Diagnostics Inc. recently announced a new agreement with OrthoSynetics, a provider of administrative, marketing and ...

3M ESPE and Quantum Dental Technologies enter into cooperative marketing agreement

ST. PAUL, Minn., USA: 3M ESPE and Quantum Dental Technologies (QDT) have entered into a cooperative marketing agreement whereby a sample kit of 3M ...

Novalar launches dental anaesthesia reversal agent

LEIPZIG, Germany: The US pharmaceutical company Novalar has launched their latest premier dental product OraVerse at the Chicago Midwinter Meeting held in ...

OroScience and ACE Surgical Supply ink distribution agreement for Periogenix

PALO ALTO, CA / NEW YORK, NY, USA: OroScience plc, an oral care life science company based in Palo Alto, CA, USA, recently announced that it has entered ...

Regional hands-on training centers for Anew narrow body implants

  Dentatus announces DMX Implants, a Dentatus division, formed to better meet the demands of its growing implant product lines. DMX Implants is ...

SensAble launches new lab solutions in Germany

SensAble Technologies, a leading provider of dental restoration design and fabrication solutions, 3-D modeling software and haptic devices, recently ...

Canadian DSO enters US market with Florida acquisition

TORONTO, Canada: Dentalcorp, the largest dental support organisation (DSO) in Canada, has added 21 supported dental clinics to its portfolio by acquiring ...

Henry Schein and vVARDIS expand distribution agreement

MELVILLE, N.Y., US: Henry Schein has announced the expansion of its agreement with Swiss company vVARDIS, granting the company exclusive US distribution ...

ImageWorks closes agreement with Sleep Group Solutions for NewTom VGi Flex in mobile cone beam units

ImageWorks Corp. and Sleep Group Solutions (SGS) recently announced an agreement whereby SGS will distribute and promote the NewTom VGi Flex mobile units ...

Suni Medical Imaging enters partnership with DentalSharing.com

SAN JOSE, CA, USA: Suni Medical Imaging, a pioneer in the manufacture of digital radiography products for dental professionals, has announced an agreement ...

Education

Live webinar
Mon. 5 October 2026
6:30 AM EST (New York)